期刊文献+

不同刺激物对细胞因子诱导的杀伤细胞分泌细胞因子的影响 被引量:4

Influence of different stimulators on secretion of cytokines by cytokine-induced killer cells
下载PDF
导出
摘要 目的:探讨抗CD3单抗联合不同浓度的抗CD28单抗对细胞因子诱导的杀伤(CIK)细胞细胞因子分泌的影响。方法:取6例肿瘤患者的外周血,分离、诱导培养,获取CIK细胞。CIK细胞成熟后用1.0 mg/L抗CD3单抗分别联合0.5、1.0、2.5 mg/L抗CD28单抗进行活化,使用ELISA方法检测细胞因子IFN-γ、IL-10、IL-2、TNF-α的分泌水平,并用胞内细胞染色法检测CD3+CD8+T细胞中IFN-γ、穿孔素的表达水平。以50μg/L佛波酯联合750μg/L离子霉素共刺激的CIK细胞作对照。结果:抗CD3单抗联合不同浓度抗CD28单抗组CIK细胞IFN-γ、IL-10、IL-2、TNF-α分泌水平和胞内穿孔素表达水平差异均无统计学意义(P>0.05)。结论:抗CD3单抗联合不同浓度抗CD28单抗共刺激对CIK细胞细胞因子的分泌无影响,临床上可选择1.0 mg/L抗CD3单抗联合0.5 mg/L抗CD28单抗活化淋巴细胞。 Aim:To investigate the effects of anti-CD3 mAb and different concentrations of anti-CD28 mAb stimuli on the secretion of cytokines by cytokine-induced killer(CIK) cells.Methods:CIK cells were obtained from peripheral blood of 6 tumor patients,and stimulated by 1.0 mg/L anti-CD3 mAb combined with 0.5,1.0 or 2.5 mg/L anti-CD28 mAb,re-spectively.The secretion of IFN-γ, IL-10, IL-2 and TNF-αwas measured by ELISA.Flow cytometry was used to detect the expressions of IFN-γand perforin in CIK cells .CIK cells stimulated by 50 μg/L PMA combined with 750 μg/L iono-mycin were the control.Results:There were no statistical differences in the secretion levels of IL-10, IL-2, IFN-γ, TNF-αor the expressions of IFN-γand perforin in CIK cells among the different stimulatory concentrations of anti-CD3 mAb/an-ti-CD28 mAb groups(P>0.05).Conclusion:There is no obvious difference in cytokine secretory capacity after stimula-tion with different concentrations of anti-CD3 mAb/anti-CD28 mAb.Thus 1.0 mg/L anti-CD3 mAb and 0.5 mg/L anti-CD28 mAb may be chosen to stimulate lymphocytes .
出处 《郑州大学学报(医学版)》 CAS 北大核心 2014年第2期166-168,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 国家自然科学基金资助项目81171986 81271815 卫生部科研攻关基金项目20110110001 河南省科技厅基础与前沿技术研究基金112300410153 122300410155 河南省科技厅科技创新人才计划项目124200510006 郑州大学第一附属医院院内创新团队基金项目
关键词 抗CD3单抗 抗CD28单抗 细胞因子 细胞因子诱导的杀伤细胞 anti-CD3 mAb anti-CD28 mAb cytokine cytokine-induced killer cell
  • 相关文献

参考文献11

  • 1Shi Y ,Wu W ,Wan T,et al. Impact of polyclonal anti-CD3/ CD28-coated magnetic bead expansion methods on T cell proliferation, differentiation and function [ J ]. Int Immuno- pharmaco1,2013,15( 1 ) :129.
  • 2Majowicz A,van der Marel S,te Velde AA,et al. Murine CD4 + CD25 cells activated in vitro with PMA/ionomyein and anti-CD3 acquire regulatory function and ameliorate experimental eolitis in vivo [ J ].BMC Gastroenterol, 2012, 12:172.
  • 3Yamada-Ohnishi Y, Azuma H, Urushibara N, et al. Cytotox- ic difference of T cells expanded with anti-CD3 mouoclonal antibody in the presence and absence of anti-CD28 mono- clonal antibody [ J ]. Stem Cells Dev, 2004,13 ( 3 ) : 315.
  • 4Wang Y, Bo J, Dai I4R, et al. CIK cells from recurrent or refractory AML patients can be efficiently expanded in vitro and used for reduction of leukemic blasts in vivo [ J ]. Exp Hemato1,2013,41 ( 3 ) :241.
  • 5王菲,王丽萍,张震,岳冬丽,段秀芳,张斌,张毅.冻存对细胞因子诱导的杀伤细胞免疫表型及细胞内因子表达的影响[J].郑州大学学报(医学版),2014,49(1):11-14. 被引量:6
  • 6Olsen I,Sollid LM. Pitfalls in determining the cytokine pro- file of human T cells [ J ]. J mmunol Methods, 2013,390 (1/2) :106.
  • 7Porter DL,Levine BL, Bunin N,et al. A phase 1 trial of do- nor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation [ J ] Blood, 2006, 107 ( 4 ) : 1325.
  • 8骆群,吕明,于鸣,黎燕.抗CD28抗体协同刺激增强抗CD3抗体体外激活T淋巴细胞并降低TGF-β的表达[J].中国实验血液学杂志,2006,14(3):547-551. 被引量:7
  • 9Li Y, Kurlander RJ. Comparison of anti-CD3 and anti- CD28-coated beads with soluble anti-CD3 for expanding human T cells: differing impact on CD8 T cell phenotype and responsiveness to restimulation [ J ]. J Transl Med, 2010,8:104.
  • 10曲梅花.CD28/B7共刺激信号及其临床意义[J].中国实验血液学杂志,2002,10(3):265-267. 被引量:12

二级参考文献40

  • 1Flens MJ,Mulder WM,Bril H,etal.Efficient expansion of tumor-infiltrating lymphocytes from solid tumors by stimulationwith combined CD3 and CD28 monoclonal antibodies.Cancer Immunol Immunother,1993;37:323-328
  • 2Garlie NK,LeFever AV,Siebenlist RE,et al.T cells co-activated with immobilized anti-CD3 and anti-CD28 as potential immunotherapy for cancer.J Immunotherapy,1999; 22:336-345
  • 3Ramireddy R,Doctschman T.TGF-b,T-cell tolerance and anti CD3 therapy.Trends MolMed,2004; 10:3-9
  • 4Suarez-Pinzon WL,Marcoux Y,Ghahary A.Gene transfection and expression of transforminggrowth factor-β1 in nonobese diabetic mouse islets protects β-cells in syngeneic isletgrafts from autoimmune destruction.Cell Transplant,2002; 11:519-528
  • 5Green EA,Gorelik L,McGregor CM,et al.CD4^+ CD25^+ T regulatory cell control anti-islet CD8^+ T cells through TGF-β-TGF-βreceptor interactions in type 1 diabetes.Proc Natl AcadSci USA,2003; 100:10878-10883
  • 6Belghith M,Bluestone JZ,Barriot S,et al.TGF-β-dependent mechanisms mediate restorationof self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.Nat Med,2003;9:1202-1208
  • 7Annunziato F,Cosmi L,Liotta F,et al.Phenotype,localization,and mechanism ofsuppression of CD4^+ CD25^+ human thymocytes.J Exp Med,2002; 196:379 -387
  • 8Piccirillo CA,Letterio JJ,Thornton AM,et al.CD4^+ CD25^+ regulatory T cells canmediate suppressor function in the absence of transforming growth factor betal productionand responsiveness.J Exp Med,2002; 196:237-246
  • 9Thompson C,Powrie F.Regulatory T cells.Cur Opin Pharmacol,2004; 4:408 -414
  • 10Bisikirska B,Colgan J,Luban J,et al.TCR stimulation with modified anti-CD3 mAb expands CD8^+ T cell population and induces CD8^+ CD25^+ Tregs.J Clin Invest,2005; 115:2904-2913

共引文献22

同被引文献41

  • 1骆群,黎燕.CD3、CD28抗体增强淋巴细胞转化功能的研究[J].军医进修学院学报,2005,26(6):479-480. 被引量:3
  • 2骆群,吕明,于鸣,黎燕.抗CD28抗体协同刺激增强抗CD3抗体体外激活T淋巴细胞并降低TGF-β的表达[J].中国实验血液学杂志,2006,14(3):547-551. 被引量:7
  • 3Shi Y, Wu W, Wan T, et al. Impact of polyclonal anti- CD3/CD28 coated magnetic bead expansion methods on T cell proliferation,differentiation and function[J]. Int Im- munopharmacol, 2013,15(1) : 129-137.
  • 4Majowiez A, Van Der Marel S, Te Velde AA, et al. Mu- rine CD4+ CD25+ cells activated in vitro with PMA/iono- mycin and anti-CD3 acquire regulatory function and amel iorate experimental colitis in vivo[J]. BMC Gastroenterol, 2012,12:172.
  • 5Cermak L, Simovd S, Pintzas A, et al. Molecular mecha nisms involved in CD43-mediated apoptosis of TF-lcells [J].J Bioll Chem,2002,277(10) :7955-7961.
  • 6Matsui, Masaru,Tahara, Masayuki,Tanaka, Masami,Tanaka, Keiko,Matsui, Makoto,Konishi, Tetsuro.CD8CD11ahigh Cells Decreased in Multiple Sclerosis but Not in Neuromyelitis Optica[J]. European Neurology . 2010 (3)
  • 7ROSENBERG SA,SPIESS P, LAFRENIERE R. A new ap- proach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes [ J ]. Science, 1986, 233 (4770) :1318.
  • 8GERMENIS AE, KARANIKAS V. Cord blood as a source of non-senescent lymphocytes for tumor immunotherapy [ J ]. J aeprod Immuno1,2010,85 ( 1 ) :47.
  • 9INTRONA M, BORLERI G, CONTI E, et al. Repeated infu- sions of donor-derived eytokine-induced killer cells in pa- tients relapsing after allogeneic stem cell transplantation: a phase I study[J]. Haematologica,2007,92(7) :952.
  • 10SCHMIDT-WOLF IG, NEGRIN RS, KIEM liP, et al. Use of a SCID mouse/human lymphoma model to evaluate cyto- kine-induced killer cells with potent antitumor cell activity [J]. J Exp Med,1991,174(1) :139.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部